GMM Pfaudler

GMM Pfaudler reported consolidated revenues of INR 3199 crores and an EBITDA of INR 381 crores for FY25, translating to an 11.9% EBITDA margin. Order intake for the year was INR 3102 crores, a 3% increase year-on-year, with a backlog of INR 1636 crores as of April 1, 2025. The company generated strong cash flows of INR 318 crores in FY25, an improvement of nearly INR 100 crores over the previous year, and achieved an 80% free cash flow to EBITDA conversion, up from 50% previously.

The India business demonstrated a robust performance in Q4 FY25, with revenues of INR 252 crores and an EBITDA of INR 44 crores, achieving an impressive 17.4% EBITDA margin. This improvement is attributed to increased volumes, a favorable product mix, and an ongoing EBITDA transformation program, with benefits expected to continue into FY26. The India backlog stands at INR 549 crores, 20% higher year-on-year, and management expects India margins to be 15%-16% in the next financial year.

GMM Pfaudler continued its global manufacturing footprint optimization, including the closure of its UK facility in Leven (on track for Q2 FY26) and the Hyderabad facility in Q3 FY25, with all associated costs accounted for in FY25 (totaling INR 20 crores for transformation and Hyderabad closure). Production from these sites is being consolidated into other facilities, notably Gujarat and the new low-cost Poland site. While international business faces uncertainty from US tariffs and a global slowdown^🌐 in chemical and pharma sectors, management is confident of not losing market share and expects a stronger Q1 FY26.

The Poland facility, a non-glass-lined manufacturing site, is strategically positioned to support European entities like Mavag and Mixel. Management expects its current revenue to triple within the first year and reach close to USD 10 million within two to three years. This site is projected to deliver at least a 30% cost benefit compared to manufacturing in Western Europe, primarily serving as an internal cost improvement play rather than a direct top-line revenue driver.

The company observes increased positivity and investment interest in India, particularly in specialty chemicals and pharmaceuticals, with agrochemicals expected to recover later in the year. Globally, while chemical and pharma remain below expectations due to tariff uncertainties, diversification into new segments like heavy engineering, mixing, and other industrial applications (e.g., oil & gas, petrochemical, mining) is helping to offset shortfalls. GMM Pfaudler is also actively exploring opportunities in defense and infrastructure in Europe.

Gregory Gelhaus has been appointed as Chief Transformation Officer to lead the group's transformation efforts, focusing on business expansion, operational efficiencies, and enhanced collaboration across geographies. The transformation program aims to diversify beyond the mature glass-lined business, targeting unlimited growth in non-glass-lined, heavy engineering, and systems verticals, which represent significantly larger addressable markets. The management team is fully aligned to drive this program over the next 12 months.